Decoy Therapeutics Inc.
DCOY | NASDAQ
$1.07
-$0.16 (-13.01%)
At close: Oct 30, 2026, 4:00 PM ET
$1.09
+$0.02 (+1.87%)
Pre-market:
Nov 2, 2026, 6:10 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 5.23M |
Cost of Revenue | 8.52M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -8.52M | n/a | n/a | n/a | n/a | 5.23M |
Operating Income | -12.61M | -5.73M | -12.89M | -31.84M | -12.81M | -7.79M |
Interest Income | 95.47K | 158.54K | 352.25K | 218.73 | n/a | n/a |
Pretax Income | -12.52M | -5.58M | -12.54M | -31.61M | -12.77M | -7.35M |
Net Income | -12.52M | -5.58M | -12.54M | -31.61M | -12.77M | -7.35M |
Selling & General & Admin | 3.73M | 4.96M | 5.72M | 7.14M | 6.1M | 6.11M |
Research & Development | 368.17K | 770.03K | 7.17M | 15.84M | 8.55M | 6.91M |
Other Expenses | n/a | n/a | n/a | 8.87M | -1.84M | n/a |
Operating Expenses | 4.1M | 5.73M | 12.89M | 31.84M | 12.81M | 13.02M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 3.05K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.61M | 5.73M | 12.89M | 31.84M | 12.81M | 13.02M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 481.59K | 64.15K | 27.21K | 17.7K | 13.79K | 5.19K |
Shares Outstanding (Diluted) | 481.59K | 64.15K | 27.21K | 17.7K | 13.79K | 5.19K |
EPS (Basic) | -25.99 | -86.92 | -461.04 | -1.79K | -926.01 | -1.42K |
EPS (Diluted) | -25.99 | -86.92 | -461.04 | -1.79K | -926.01 | -1.42K |
EBITDA | -12.51M | -5.57M | -12.53M | -22.97M | -12.75M | -7.59M |
EBIT | -12.52M | -5.58M | -12.54M | -22.98M | -12.77M | -7.61M |
Depreciation & Amortization | 7.15K | 4.42K | 10.05K | 6.68K | 19.18K | 18.06K |
Add to Watchlist
Select watchlists to add or remove DCOY